GBA 集團(00261.HK)上半年淨虧3200萬港元 同比收窄38.5%
格隆匯8月30日丨GBA 集團(00261.HK)公佈中期業績,2021年首六個月,集團收入為1900萬港元,較去年同期下跌約93.9%。去年同期的收入主要來自中建•俊公館項目第1.2期的物業單位銷售,由於中建•俊公館項目的其他期數仍在發展中而尚未完工,因此,在該期間該項目沒有確認任何銷售而引致收入下降。
報吿期內,母公司股權擁有人應占集團淨虧損為3200萬港元,較去年同期減少約38.5%。今期虧損減少主要缺少了產品貿易業務的虧損,而該業務已於去年終止經營並在去年上半年錄得虧損1400萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.